A phase II study of gefitinib in patients with metastatic melanoma.
Patel SP, Kim KB, Papadopoulos NE, Hwu WJ, Hwu P, Prieto VG, Bar-Eli M, Zigler M, Dobroff A, Bronstein Y, Bassett RL, Vardeleon AG, Bedikian AY.
Patel SP, et al. Among authors: zigler m.
Melanoma Res. 2011 Aug;21(4):357-63. doi: 10.1097/CMR.0b013e3283471073.
Melanoma Res. 2011.
PMID: 21738104
Free PMC article.
Clinical Trial.